World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
53950
World Ranking
12891
National Ranking
690

Overview

Johannes F.E. Mann is affiliated with the University of Erlangen-Nuremberg in Germany. Their research predominantly spans the field of Medicine, with a significant focus on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Molecular Biology, and Pulmonary and Respiratory Medicine.

The scientist's work covers several main topics, including:

  • Diabetes Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Metabolism, Diabetes, and Cancer
  • Diabetes Management and Research
  • Chronic Kidney Disease and Diabetes
  • Dialysis and Renal Disease Management
  • Pancreatic function and diabetes

Johannes F.E. Mann has published extensively in several key journals. Frequent publication venues include:

  • Journal of the American Society of Nephrology
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Diabetes Care
  • New England Journal of Medicine

Some of the recent scientific papers associated with or relevant to this field of study include:

  • "Dapagliflozin in Patients with Chronic Kidney Disease," 2020, New England Journal of Medicine
  • "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease," 2021, Kidney International
  • "Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes," 2024, New England Journal of Medicine
  • "Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease," 2021, Kidney International
  • "The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease," 2023, Nephrology Dialysis Transplantation

Johannes F.E. Mann has collaborated frequently with other researchers in the field. Frequent co-authors include:

  • Peter Rossing
  • Thomas Idorn
  • Katherine R. Tuttle
  • Hiddo J.L. Heerspink
  • Kenneth W. Mahaffey

Best Publications

  • Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

    Steven P. Marso;Gilbert H. Daniels;Kirstine Brown-Frandsen;Peter Kristensen

  • Dapagliflozin in Patients with Chronic Kidney Disease

    Hiddo J.L. Heerspink;Bergur V. Stefánsson;Ricardo Correa-Rotter;Glenn M. Chertow

  • Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals

    Hertzel C. Gerstein;Johannes F. E. Mann;Qilong Yi;Bernard Zinman

  • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

    Christoph Wanner;Vera Krane;Winfried März;Manfred Olschewski

  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

    Ron T Gansevoort;Ricardo Correa-Rotter;Brenda R Hemmelgarn;Tazeen H Jafar

  • Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

    Giuseppe Maschio;Daniele Alberti;Gérard Janin;Francesco Locatelli

  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

    Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal

  • Chronic Kidney Disease Effects on the Cardiovascular System

    Ernesto L. Schiffrin;Mark L. Lipman;Johannes F.E. Mann

  • Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial

    J.F.E Mann;H.C Gerstein;J Pogue;J Bosch

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.: A collaborative meta-analysis of high-risk population cohorts

    Marije van der Velde;Kunihiro Matsushita;Josef Coresh;Brad C. Astor

  • Liraglutide and Renal Outcomes in Type 2 Diabetes

    Johannes F.E. Mann;David D. Ørsted;Kirstine Brown-Frandsen;Steven P. Marso

  • Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

    Regina Kunz;Chris Friedrich;Marcel Wolbers;Johannes F E Mann

  • KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

    Alfred K. Cheung;Tara I. Chang;William C. Cushman;Susan L. Furth

  • Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events

    Martin J. O'Donnell;Salim Yusuf;Andrew Mente;Peggy Gao

  • Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

    Jürgen Floege;Thomas Rauen;Frank Eitner

  • Avosentan for Overt Diabetic Nephropathy

    Johannes F.E. Mann;Damian Green;Kenneth Jamerson;Luis M. Ruilope

  • Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

    Gilles R. Dagenais;Qilong Yi;Johannes F.E. Mann;Jackie Bosch

  • Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

    Andrew Mente;Martin O'Donnell;Martin O'Donnell;Sumathy Sumathy Rangarajan;Gilles Dagenais

  • Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes: Results of the HOPE Study and MICRO-HOPE Substudy

    Eva Lonn;Salim Yusuf;Byrcon Hoogwerf;Janice Pogue

  • Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

    Michel Marre;Michel Lievre;Gilles Chatellier;Johannes F E Mann

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Eberhard Ritz
Eberhard Ritz Heidelberg University
Koon K. Teo
Koon K. Teo McMaster University
Friedrich C. Luft
Friedrich C. Luft Charité - University Medicine Berlin
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Roland E. Schmieder
Roland E. Schmieder University of Erlangen-Nuremberg
Eva Lonn
Eva Lonn McMaster University
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Peter Rossing
Peter Rossing University of Copenhagen
Michael A. Nauck
Michael A. Nauck Ruhr University Bochum

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in a healthcare career but prefer alternative pathways to becoming a physician, there are several flexible online options. Direct entry nurse practitioner programs for non-nurses online enable students from non-nursing backgrounds to enter advanced nursing roles through accelerated study. These programs are ideal if you want to move quickly into high-responsibility clinical work.

For those starting out, you may be wondering what is the easiest nursing program to get into. Many schools now offer accessible entry points to a nursing career, even for those with limited prior experience, making it a popular alternative for aspiring healthcare workers.

Interested in healthcare administration or support? Financial support is available for training too. Check out financial aid for medical billing and coding online classes for programs that can launch a non-clinical medical career without a medical degree.

Additionally, some nursing programs, such as lpn to rn programs without teas test requirements, can streamline your advancement without extensive entrance exams. Exploring these related pathways can help you join the medical field in a way that fits your goals and background.

Best Scientists Citing Johannes F.E. Mann

Trending Scientists